Welcome to LookChem.com Sign In|Join Free

Article Doi

The first enzymatic degradation products of the antibiotic moenomycin A.

DOI: 10.1016/S0040-4020(01)86589-3

Source and publish data:

Tetrahedron p. 8401 - 8418 (1992)

Update date:2022-08-02

Topics:

Authors:

Metten, Karl-HeinzMetten, Karl-Heinz

Hobert, KurtHobert, Kurt

Marzian, SusanneMarzian, Susanne

Hackler, Ulrich E.Hackler, Ulrich E.

Heinz, UweHeinz, Uwe

Welzel, PeterWelzel, Peter

Aretz, WernerAretz, Werner

Boettger, DirkBoettger, Dirk

Hedtmann, UdoHedtmann, Udo

Seibert, GerhardSeibert, Gerhard

Markus, AstridMarkus, Astrid

Limbert, MichaelLimbert, Michael

Van Heijenoort, YvelineVan Heijenoort, Yveline

Van Heijenoort, JeanVan Heijenoort, Jean

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/S0040-4020(01)86589-3

Moenomycin A was degraded by enzymatic cleavage of the bond between the moenuronic acid moiety and the phosphate group. The phosphoric acid monoester 4a could be dephosphorylated further to yield 3a. Compound 3a was used to confirm the previous configurat

View More

Full text of DOI:10.1016/S0040-4020(01)86589-3

Products guided by the article

Product name:tert-butyldipenylsilanyl (R)-3-(tert-butyldiphenylsilanyloxy)-2-((2Z,6E,13E)-3,8,8,14,18-pentamethyl-11-methylene-nonadeca-2,6,13,17-tetraenyloxy)-propanoate

Cas No:145012-55-1

145012-55-1

R&D Labs maybe for 145012-55-1

Relevant to this article

Hot Product